Aeglea Biotherapeutics shares owned by Deutsche Bank Aktiengesellschaft
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Deutsche Bank Aktiengesellschaft
from 13F filings
Historical chart of Deutsche Bank Aktiengesellschaft investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Aeglea Biotherapeutics by Deutsche Bank Aktiengesellschaft
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $731k | 31k | 23.28 |
2024-09-30 | $633k | 22k | 29.41 |
2024-06-30 | $382k | 16k | 23.51 |
2024-03-31 | $11k | 298 | 37.93 |
More positions owned by Deutsche Bank Aktiengesellschaft
View all positions for Deutsche Bank Aktiengesellschaft